Revolutionary Inhaler Promises to Transform Asthma Care
A new inhaler called Airsupra, which combines a bronchodilator and an anti-inflammatory steroid, has been shown to significantly reduce severe asthma attacks and steroid use compared to albuterol alone, potentially changing how mild asthma is treated by addressing both symptoms and underlying inflammation simultaneously.